| A review of morphine and morphine-6-glucuronide’s pharmacokinetic–pharmacodynamic relationships in experimental and clinical pain E Sverrisdóttir, TM Lund, AE Olesen, AM Drewes, LL Christrup, ... European Journal of Pharmaceutical Sciences 74, 45-62, 2015 | 153 | 2015 |
| The relative timing of trunk muscle activation is retained in response to unanticipated postural-perturbations during acute low back pain S Boudreau, D Farina, L Kongstad, D Buus, J Redder, E Sverrisdóttir, ... Experimental brain research 210, 259-267, 2011 | 63 | 2011 |
| Pharmacokinetic models of morphine and its metabolites in neonates:: Systematic comparisons of models from the literature, and development of a new meta-model KR Knøsgaard, DJR Foster, M Kreilgaard, E Sverrisdóttir, RN Upton, ... European Journal of Pharmaceutical Sciences 92, 117-130, 2016 | 37 | 2016 |
| Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics LM Nielsen, E Sverrisdóttir, TB Stage, S Feddersen, K Brøsen, ... European Journal of Pharmaceutical Sciences 99, 337-342, 2017 | 32 | 2017 |
| Sensitivity of quantitative sensory models to morphine analgesia in humans AE Olesen, C Brock, E Sverrisdóttir, IM Larsen, AM Drewes Journal of Pain Research, 717-726, 2014 | 31 | 2014 |
| Modelling concentration–analgesia relationships for morphine to evaluate experimental pain models E Sverrisdóttir, DJR Foster, RN Upton, AE Olesen, TM Lund, ... European Journal of Pharmaceutical Sciences 66, 50-58, 2015 | 19 | 2015 |
| Absorption of bupivacaine after administration of a lozenge as topical treatment for pain from oral mucositis S Mogensen, E Sverrisdóttir, K Sveinsdóttir, C Treldal, K Jensen, ... Basic & clinical pharmacology & toxicology 120 (1), 71-78, 2017 | 15 | 2017 |
| Midazolam pharmacokinetics in obese and non-obese children and adolescents C Gade, E Sverrisdóttir, K Dalhoff, J Sonne, MØ Johansen, ... Clinical Pharmacokinetics 59, 643-654, 2020 | 10 | 2020 |
| Artificial neural network vs. pharmacometric model for population prediction of plasma concentration in real‐world data: a case study on valproic acid H Soeorg, E Sverrisdóttir, M Andersen, TM Lund, M Sessa Clinical Pharmacology & Therapeutics 111 (6), 1278-1285, 2022 | 8 | 2022 |
| Utilizing drug-target-event relationships to unveil safety patterns in pharmacovigilance AS Hauser, AJ Kooistra, E Sverrisdóttir, M Sessa Expert Opinion on Drug Safety 19 (8), 961-968, 2020 | 6 | 2020 |
| The PHARMACOM‐EPI framework for integrating pharmacometric modelling into pharmacoepidemiological research using real‐world data: Application to assess death associated with … H Soeorg, E Sverrisdottir, M Andersen, TM Lund, M Sessa Clinical Pharmacology & Therapeutics 111 (4), 840-856, 2022 | 5 | 2022 |
| Pharmacom-epi: A framework for integrating pharmacometric modeling into Pharmacoepidemiological research using real-world data H Soeorg, E Sverrisdottir, M Andersen, TM Lund, M Sessa PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 568-569, 2022 | | 2022 |
| O35 Midazolam pharmacokinetics in children with obesity C Gade, E Sverrisdóttir, K Dalhoff, J Sonne, HR Christensen, J Burhenne, ... Archives of Disease in Childhood 104 (6), e15-e16, 2019 | | 2019 |
| Population Pharmacokinetic-pharmacodynamic Modelling of Morphine-induced Analgesia: PhD Thesis E Sverrisdóttir Faculty of Health and Medical Sciences, University of Copenhagen, 2014 | | 2014 |
| Pain-induced changes in trunk muscle activation during unanticipated postural perturbations E Sverrisdóttir, J Redder, D Buus, L Kongstad, S Boudreau, D Farina, ... Congress of the International Society of Electrophysiology and Kinesiology, 2010 | | 2010 |
| The maintenance of full differentiation potential of the human embryonic stem cell lines; CLS1 and CLS2 JH Henriksen, L Kongstad, KM Møller, SS Petersen, MT Rasmussen, ... | | |
| The Effect of Human Adipose Derived Stem Cells on Lymphocyte Proliferation JH Henriksen, L Kongstad, A Rahi, E Sverrisdóttir | | |
| Population Approach Group Europe Population Approach Group Europe E Sverrisdottir | | |
| Modelling drug-drug interactions between morphine and methylnaltrexone E Sverrisdóttir, M Kreilgaard, A Brokjær, KK Miltersen, AE Olesen, ... | | |
